Newsroom
Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology development decisions. The START Center for Cancer Research (“START”), today announced the appointment of Frank Smith, PhD, MBA, as President of XenoSTART, its preclinical business unit. In this role, Dr.
Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices The START Center for Cancer Research (“START”), the world’s largest community-based network specializing in early-phase oncology trials, today announced the appointment of Navid Hafez, MD,
The first START site in New York launches new strategic partnership to provide cutting-edge cancer research Northwell Health and The START Center for Cancer Research held a ceremonial ribbon-cutting to unveil Northwell-START New York-Long Island, which reflects a $5.7 million investment for a 10,000-square foot, state-of-the-art early-phase cancer clinical trial
New START site at HM Montepríncipe University Hospital offers clinical trial access for children with cancer The START Center for Cancer Research (“START”), the world’s largest community-based network specializing in early-phase oncology clinical trials, together with HM Hospitales, announces the launch of a pediatric onco-hematology clinical research unit at HM
Expanded partnership positions XenoSTART and Minerva Imaging at the forefront of radiopharmaceuticals — one of the fastest-growing areas in oncology drug development. The START Center for Cancer Research (“START”), its preclinical division XenoSTART, and Minerva Imaging today announced an expansion of their decade-long partnership to establish the industry’s most comprehensive
START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem The START Center for Cancer Research (“START”), the leading global community-based early-phase oncology research network, today announced a strategic
